AdaptHealth Q3 net revenue $820.3M (+1.8%), adj. EBITDA $170.1M (+3.5%) beat expectations; organic growth 5.1%

AdaptHealth Corp.

2025-Q3 EPS reported $0.21 revenue$2,398,568,000

Net income $24.5M vs $22.9M; YTD free cash flow $140.1M vs $162.7M.
Reduced debt by $225M YTD; net leverage ratio 2.68x (target 2.50x).
Signed capitated HME deal for ~170k members; myApp users up 271k from 118k.
Maintained FY2025 guidance: rev $3.18-3.26B, adj. EBITDA $642-682M, FCF $170-190M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.